Aura Biosciences, Inc.AURANASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank40
3Y CAGR-0.1%
5Y CAGR+37.6%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-0.1%/yr
Annual compound
5Y CAGR
+37.6%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$151.97M-32.7%
2023$225.85M+15.5%
2022$195.58M+28.4%
2021$152.31M+686.6%
2020$19.36M-37.1%
2019$30.76M-